Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
Puente J, González-Del-Alba A, Sala-Gonzalez N, Méndez-Vidal MJ, Pinto A, Rodríguez Á, Cuevas Sanz JM, Muñoz Del Toro JR, Useros Rodríguez E, García García-Porrero Á, Vázquez S. Puente J, et al. Among authors: munoz del toro jr. BMC Cancer. 2019 Aug 5;19(1):766. doi: 10.1186/s12885-019-5974-9. BMC Cancer. 2019. PMID: 31382926 Free PMC article.
Clinical drivers for imaging testing in non-metastatic castration-resistant prostate cancer in clinical practice: Results of the IDENTIFICA study.
Cózar Olmo JM, Carballido Rodríguez J, Rubio-Briones J, Useros Rodríguez E, Muñoz Del Toro J, García García-Porrero Á, Juárez-Soto Á; en nombre del grupo de investigadores del estudio IDENTIFICA. Cózar Olmo JM, et al. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):198-206. doi: 10.1016/j.acuro.2020.12.001. Epub 2021 Feb 6. Actas Urol Esp (Engl Ed). 2021. PMID: 33558084 English, Spanish.
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis.
Rodriguez-Vida A, Rodríguez-Alonso A, Useros-Rodríguez E, Lopez-Campos F, Amor-Carro O, Arribas-Ruiz A, Martinez-Torres J, Roca-Pardiñas J, Quesada-García A, Muñoz-Del-Toro JR, Juárez-Soto Á. Rodriguez-Vida A, et al. Among authors: munoz del toro jr. Clin Genitourin Cancer. 2022 Apr;20(2):197.e1-197.e10. doi: 10.1016/j.clgc.2021.11.008. Epub 2021 Nov 21. Clin Genitourin Cancer. 2022. PMID: 34920959 Free article. Review.